证券代码：002206 证券简称：海利得 公告编号：2025-056 浙江海利得新材料股份有限公司 本公司及全体董事会成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 一、本期业绩预计情况 项 目 本报告期 上年同期 归属于上市公司 盈利：28,000.00 万元–31,000.00 万元 盈利：18,964.14 万元 股东的净利润 比上年同期增长：47.65% - 63.47% 扣除非经常性损 盈利：32,500.00 万元–35,500.00 万元 盈利：18,670.19 万元 益后的净利润 比上年同期增长：74.07% - 90.14% 基本每股收益 盈利：0.25 元/股–0.27 元/股 盈利：0.16 元/股 二、与会计师事务所沟通情况 本次业绩预告未经过会计师事务所审计。 三、业绩变动原因说明 （一）主营业务影响 （二）非经常性损益的影响 报告期内，非经常性损益的影响主要是为规避和防范外汇汇率波动带来的 经营风险，公司始终坚持外汇风险管理中性原则，适当开展远期结售汇、外汇 期权等业务进行对冲，二季度以来人民币对欧元大幅贬值，公司欧元资产汇率 变动带来汇兑收益的 ...

每股转增0.40股 ? 相关日期 新增无限售条件流 证券代码：688157 证券简称：松井股份 公告编号：2025-029 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 公司存在首发战略配售股份，首发战略配售股份已全部上市流通 股权登记日 除权（息）日 现金红利发放日 通股份上市日 一、 通过分配、转增股本方案的股东大会届次和日期 本次利润分配及转增股本方案经公司2025 年 5 月 20 日的2024年年度股东大会 审议通过。 二、 分配、转增股本方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 本次利润分配及转增股本以方案实施前的公司总股本111,736,486股为基数，每 股派发现金红利0.23211元（含税） ，以资本公积金向全体股东每股转增0.40股，共 计 派 发 现 金 红 利 25,935,155.77 元 ， 转 增 44,694,594 股 ， 本 次 分 配 后 总 股 本 为 三、 ...

【DT新材料】 获悉，近日， 关于 内蒙古双欣环保材料股份有限公司 年产 15万吨 乙烯法醋酸乙烯及 6万吨 特种聚乙烯醇项目环评 第二次公示。 · 政策发展 · 市场分析 · 投融资 · 供应链 · Al赋能 2025"新塑奖"评选颁奖盛典 内蒙古双欣环保材料股份有限公司 成立于2009年6月，注册资本86,000万元。双欣环保是一家专业从事聚乙烯醇（PVA）、聚乙烯醇特种纤维、醋酸乙 烯（VAC）、碳化钙（电石）等PVA产业链上下游产品的研发、生产、销售的高新技术企业，拥有聚乙烯醇全产业链布局。其中， 电石作为化工"基 石"，主要用于生产乙炔进而合成PVC、PVA、BDO等重要化工材料 ，是有机化学工业上游的基础性原材料。 说明： 本文部分素材来自于 内蒙古双欣环保材料股份有限公司 及网络公开信息，由作者重新编写，系作者个人观点，本平台发布仅为了传达一种不同观点，不代表对该观点赞同或支持。如果有 任何问题，请联系我们：15355132586（微信号：dtmaterial） | 全体大会 高分子产业年会(全体大会) 项目 总投资 201173.59万元 ， 建设规模包括 15万吨/年乙烯法醋酸乙烯(VAC) ...

2025.07. 10 7月10日晚间，沪深两市多家上市公司发布公告，以下是第一财经对一些重要公告的汇总，供投资者 参考。 【品大事】 塞力医疗：旗下联营企业治疗性降压疫苗项目试验能否成功还存在重大不确定性 塞力医疗(603716)发布股票交易异常波动公告，公司股票连续3个交易日内日收盘价格涨幅偏离值累 计超过20%，属于股票交易异常波动的情形。公司关注到近期市场对创新药业务关注度较高。公司 旗下联营企业华纪元生物是公司于2020年1月投资的参股公司，持有其15.61%的股份，投资金额 1066.6万元，华纪元生物2024年营业收入2.68万元，净利润-238.23万元。其治疗性降压疫苗项目 HJY-ATRQβ-001已完成概念验证（POC）阶段研究和临床前研究，已于2025年6月6日获得国家药 监局（NMPA）的新药临床试验申请（IND）受理，后续还需经一期、二期临床试验，试验能否成功 还存在重大不确定性。上述投资目前对公司主营业务的影响较小，敬请投资者注意相关风险，理性决 策，审慎投资。 人福医药：股东招商生科取得增持股份专项贷款承诺函 人福医药(600079)公告，公司近日收到股东招商生命科技（武汉）有 ...

智通财经7月10日电，药石科技(300725.SZ)公告称，公司员工持股平台南京诺维科思创业投资合伙企业 （有限合伙）计划在公告披露之日起十五个交易日后的三个月内，以集中竞价、大宗交易方式减持其持 有的全部公司股份，不超过540.47万股，占剔除已回购股份后总股本的2.7174%。 药石科技：员工持股平台拟减持不超2.72%公司股份 ...

Core Viewpoint - Jiangxin Fiber Technology Co., Ltd. (hereinafter referred to as Jiangxin) has been accepted for IPO on the Beijing Stock Exchange, aiming to raise 346 million yuan for new projects and R&D in high-performance fibers [2] Company Overview - Jiangxin was established in 2010 with a registered capital of 56.85 million yuan, focusing on the R&D, production, and sales of differentiated polyester filament and fiber masterbatch [2] - The company’s products are utilized in outdoor goods and apparel, serving brands such as ASHLEY, Anta, Lululemon, and Uniqlo [2] Financial Performance - Projected revenues for 2022, 2023, and 2024 are 289 million yuan, 300 million yuan, and 369 million yuan respectively, with net profits (after non-recurring items) of 62.75 million yuan, 54.04 million yuan, and 65.90 million yuan [2] - The gross profit margins for the same years are 35.39%, 32.04%, and 31.61%, significantly higher than comparable companies in the industry [2] - The decline in net profit for 2023 is attributed to increased depreciation costs from the use of a new factory [2] Management Team - The chairman and general manager, Gu Jianhua, controls 72.99% of the company’s shares and is the actual controller [4] - Gu Jianhua, born in 1973, has a background in textile engineering and has held various positions in the fiber industry before founding Jiangxin [4] - The executive vice president, Tong Weihong, also has a background in textile engineering and has extensive experience in the fiber sector [4] Board of Directors - The current board members include Gu Jianhua (Chairman), Tong Weihong (Executive Vice President), and several independent directors, all serving from May 11, 2024, to May 10, 2027 [5]

Group 1 - The core viewpoint of the news is that Zhuoyue New Energy's stock has declined, and its current PE ratio is significantly lower than the industry average, indicating potential undervaluation [1][2] - Zhuoyue New Energy's stock closed at 43.83 yuan, down 5.92%, with a rolling PE ratio of 29.01 times and a total market value of 5.26 billion yuan [1] - The company operates in the chemical products industry, which has an average PE ratio of 47.71 times and a median of 41.07 times, placing Zhuoyue New Energy at the 80th position in the industry ranking [1][2] Group 2 - As of the first quarter of 2025, nine institutions hold shares in Zhuoyue New Energy, including five funds, two others, one insurance company, and one brokerage, with a total holding of 91.89 million shares valued at 4.13 billion yuan [1] - The main business of Zhuoyue New Energy is the production of biodiesel and the utilization of bio-based materials from waste oil, with key products including various grades of biodiesel and other bio-based materials [1] - The latest financial report for the first quarter of 2025 shows that the company achieved an operating income of 709 million yuan, a year-on-year decrease of 18.39%, while net profit increased by 111.22% to 61.31 million yuan, with a sales gross margin of 8.67% [1]

博腾股份（300363）公告，预计2025年上半年净利润为0万元-3000万元，上年同期为亏损1.7亿元。 ...

7月10日，巍华新材今日收盘18.48元，下跌1.02%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到32.53倍，总市值63.82亿元。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13巍华新材32.5325.171.6063.82亿行业平均 34.3936.025.99107.51亿行业中值36.3138.681.9253.78亿1卫星化学8.949.751.86591.87亿2鲁西化工 10.699.881.05200.38亿3苏盐井神10.719.801.2175.35亿4博源化工11.9710.451.27189.28亿5华鲁恒升 12.8911.701.44456.70亿6江盐集团13.5711.641.2153.67亿7川恒股份13.6214.582.26139.43亿8氯碱化工 14.2214.581.29114.83亿9江天化学14.6114.044.3341.79亿10君正集团14.9216.491.64462.40亿11宝丰能源 15.5718.062.521144.74亿12鲁北化工16.6015.681.2840.91亿 从行业市盈率排名来看，公司所处的化学 ...

Core Viewpoint - Huide Technology plans to raise up to 580 million yuan through a private placement of A-shares to no more than 35 specific investors, with the net proceeds allocated entirely to a polyurethane new materials project, despite having substantial cash reserves [1][2]. Financial Status - As of March 31, 2025, Huide Technology reported a strong financial position with cash holdings of 473 million yuan, minimal short-term borrowings of 24 million yuan, and a low debt-to-asset ratio of 30% [1]. - The company's operating cash flow has significantly declined, with a net cash flow drop of 88.33% year-on-year to 27.91 million yuan in 2024, and a negative cash flow of 5.84 million yuan in Q1 2025, indicating weakened cash generation ability [1]. Revenue Trends - Huide Technology has experienced a decline in revenue for three consecutive years, with revenues of 3.017 billion yuan, 2.712 billion yuan, and 2.671 billion yuan for 2022, 2023, and 2024 respectively, reflecting decreases of 5.46%, 10.12%, and 1.51% [1]. Strategic Expansion Considerations - The private placement pricing mechanism is based on the average stock price over the 20 trading days prior to the issuance date, ensuring a market-driven approach to avoid pricing issues due to stock price fluctuations [2]. - The funds raised will be used for a polyurethane new materials project, which has a projected internal rate of return of 24.14% after tax and an investment payback period of 5.3 years, indicating promising economic benefits [2]. - Market reactions to the private placement are mixed, with some investors supporting the move for long-term growth and competitiveness, while others express concerns about potential dilution of earnings per share and the risk of the company being perceived as "raising money" despite its cash reserves [2].